Related Experiment Videos
[Chronic inflammatory demyelinating polyneuropathy. Report of six cases]
1Departamento de Neurología y Neurocirugía, Hospital Clínico de la U de Chile, Santiago de Chile.
Revista Medica De Chile
|November 1, 1996
Summary
Chronic inflammatory demyelinating polyneuropathy (CIDP) can present atypically. Steroid treatment effectively improved symptoms in six patients, regardless of presentation, highlighting its therapeutic value.
Area of Science:
- Neurology
- Clinical Medicine
Context:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) presents as a heterogeneous neurological disorder.
- Characterized by symmetrical motor and sensory deficits, absent reflexes, and elevated cerebrospinal fluid protein.
Purpose:
- To report on the clinical presentation and treatment outcomes of six patients with CIDP.
- To evaluate the effectiveness of steroid therapy in managing CIDP symptoms.
Summary:
- Six patients (three male, aged 41-70) with CIDP were studied.
- Four presented classically, while two had asymmetrical, predominantly upper limb paresis with proximal nerve conduction blocks.
- All patients underwent thorough diagnostic workups to exclude underlying conditions and were followed for 2-14 months.
Impact:
- Steroid treatment demonstrated significant improvement in muscle strength and sensory function across all studied patients.
- This supports the use of steroids as a primary treatment modality for CIDP, including atypical presentations.